LEQVIO

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Hong Kong SAR China, Israel, Italy, Lithuania, Poland, Romania, UK.

Active ingredients

The drug LEQVIO contains one active pharmaceutical ingredient (API):

1	Inclisiran UNII UOW2C71PG5 - INCLISIRAN
	Inclisiran is a cholesterol-lowering, double-stranded, small interfering ribonucleic acid (siRNA), conjugated on the sense strand with triantennary N-acetylgalactosamine (GalNAc) to facilitate uptake by hepatocytes. It is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet.
	Read more about Inclisiran

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEQVIO Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AX16		C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1834950, 1886261
FI	Lääkealan turvallisuus- ja kehittämiskeskus	195659
FR	Base de données publique des médicaments	67968207
GB	Medicines & Healthcare Products Regulatory Agency	394944
HK	Department of Health Drug Office	67211
IL	מִשְׂרַד הַבְּרִיאוּת	8899
IT	Agenzia del Farmaco	049274018, 049274020
LT	Valstybinė vaistų kontrolės tarnyba	1091528
PL	Rejestru Produktów Leczniczych	100444455
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67346001, W67346002